EAT:NYSEBrinker International, Inc. Analysis
Data as of 2026-05-21 - not real-time
$131.18
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Brinker International (EAT) is trading at $131.18, well below its 20‑day ($138.81), 50‑day ($143.96) and 200‑day ($143.80) simple moving averages, with a bearish MACD histogram and an RSI of 43.1, indicating short‑term momentum weakness and a neutral‑to‑bearish technical outlook. The stock’s 30‑day volatility is high at 70.7% and beta exceeds 1.0, while volume has been trending down, suggesting heightened price sensitivity and limited buying pressure. On the valuation side, a trailing P/E of 12.8 and forward P/E of 10.5 appear modest, but a price‑to‑book of 13.86 and a discounted cash‑flow fair value of $69.65 place the current price in the overvalued range, with analysts projecting a 41.9% upside to a median target of $189.
Despite the technical frailty, the company delivered Q1 CY2026 sales up 3.2% YoY to $1.47 bn, beat non‑GAAP EPS expectations ($2.90 vs. consensus) and raised its 2026 guidance on Chili’s momentum, underpinning a “buy” consensus from 21 analysts. However, a debt‑to‑equity ratio of 430.5, negligible ROE (1.4%), and zero dividend payout raise concerns about financial leverage and capital return sustainability. The blend of modest growth, strong cash flow generation, and sector‑cyclical exposure suggests a balanced growth‑value profile, but the high leverage and valuation premium warrant caution.
Despite the technical frailty, the company delivered Q1 CY2026 sales up 3.2% YoY to $1.47 bn, beat non‑GAAP EPS expectations ($2.90 vs. consensus) and raised its 2026 guidance on Chili’s momentum, underpinning a “buy” consensus from 21 analysts. However, a debt‑to‑equity ratio of 430.5, negligible ROE (1.4%), and zero dividend payout raise concerns about financial leverage and capital return sustainability. The blend of modest growth, strong cash flow generation, and sector‑cyclical exposure suggests a balanced growth‑value profile, but the high leverage and valuation premium warrant caution.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price below key moving averages and bearish MACD
- Support level near $124.96
- Recent earnings beat but limited upside on technicals
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Guidance raise and strong Chili’s momentum
- Analyst consensus buy with median target $189
- Forward P/E compression to 10.5 indicating value appeal
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- High debt‑to‑equity ratio and low ROE
- Stable franchise cash flows supporting resilience
- Consumer‑cyclical exposure to economic cycles
Key Metrics & Analysis
Financial Health
Revenue Growth3.20%
Profit Margin8.07%
P/E Ratio12.8
ROE139.22%
ROA13.88%
Debt/Equity430.54
P/B Ratio13.9
Op. Cash Flow$757.8M
Free Cash Flow$317.6M
Technical Analysis
TrendNeutral
RSI43.1
Support$124.96
Resistance$155.04
MA 20$138.81
MA 50$143.96
MA 200$143.80
MACDBearish
VolumeDecreasing
Fear & Greed Index89.88
Valuation
Fair Value$69.65
Target Price$186.10
Upside/Downside41.86%
GradeOvervalued
TypeBlend
Risk Assessment
Beta1.08
Volatility70.72%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.